The role of probiotic supplementation in reducing Helicobacter pylori recurrence after classic quadruple therapy
BackgroundHelicobacter pylori (H. pylori) infection remains a global public health issue, closely linked to peptic ulcer disease, gastric cancer, and MALT lymphoma. Although classic bismuth-containing quadruple therapy achieves high eradication rates, recurrence after treatment is still a significan...
Saved in:
| Main Authors: | Jie Zhao, Jieyun Chen, Yanqing Wang, Chen Zhu, Chenjing Xia, Wei Yang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1621090/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Randomized multicenter trial comparing minocycline and ornidazole with classical quadruple therapy in Helicobacter pylori treatment
by: Yi Lin, et al.
Published: (2025-05-01) -
Eradication of Helicobacter pylori: a prospective comparative randomized trial of standard versus optimized quadruple therapy
by: Salma Souissi, et al.
Published: (2024-12-01) -
Effect of Saccharomyces boulardii supplementation to bismuth quadruple therapy on Helicobacter pylori eradication
by: Yi-Zhou Jiang, et al.
Published: (2025-04-01) -
The efficacy of quadruple therapy in non-ulcer Helicobacter Pylory gastritis in children: A prospective study
by: Hien Thi Phan, et al.
Published: (2025-01-01) -
The double-edged sword of probiotic supplementation on gut microbiota structure in Helicobacter pylori management
by: Ali Nabavi-Rad, et al.
Published: (2022-12-01)